Published on in Vol 4, No 10 (2020): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17898, first published .
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study

Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study

Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study

JMIR Formative Res: Follow-Up of #Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Report… https://t.co/1We8I3bWYe

1:56 PM · Oct 28, 2020

0
0

New article: Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outco… https://t.co/LUb5QSe1lC

10:03 AM · Oct 29, 2020

0
0

Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KIS… https://t.co/4U49lU1qic

3:09 AM · Oct 30, 2020

0
0

This prospective study, conducted in collaboration between @KaikuHealth and Oulu University Hospital, suggests that… https://t.co/7fitCwM3Ot

11:55 AM · Nov 12, 2020

4
2

RT @KaikuHealth: This prospective study, conducted in collaboration between @KaikuHealth and Oulu University Hospital, suggests that digita…

12:39 PM · Nov 12, 2020

4
2

RT @KaikuHealth: This prospective study, conducted in collaboration between @KaikuHealth and Oulu University Hospital, suggests that digita…

6:40 AM · Nov 13, 2020

4
2